Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC pulmonary …, 2022 - Springer
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis
Background Sarcopenia, defined using abdominal computed tomography (CT), has been
used as a prognostic marker for patients with idiopathic pulmonary fibrosis (IPF). However …
used as a prognostic marker for patients with idiopathic pulmonary fibrosis (IPF). However …
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease
K Hirai, A Tanaka, T Homma, Y Goto, K Akimoto, T Uno… - Clinical nutrition, 2021 - Elsevier
Background & aims Sarcopenia is common in patients with chronic obstructive pulmonary
disease (COPD). Serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a …
disease (COPD). Serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a …
Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis
K Fujita, H Ohkubo, A Nakano, Y Mori… - Chronic Respiratory …, 2022 - journals.sagepub.com
Objectives Sarcopenia is a syndrome characterized by reduced muscle mass and function. It
is well-recognized as a complication in chronic diseases such as chronic obstructive …
is well-recognized as a complication in chronic diseases such as chronic obstructive …
Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional …
X Zhao, R Su, R Hu, Y Chen, X Xu, Y Yuan, J Zhang… - BMC geriatrics, 2023 - Springer
Background Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle
mass and function and has a negative impact on clinical outcomes associated with chronic …
mass and function and has a negative impact on clinical outcomes associated with chronic …
Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients
Background Sarcopenia can contribute to negative outcomes in patients with various lung
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …
Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer
T Tang, L Xie, S Hu, L Tan, X Lei, X Luo… - Journal of cachexia …, 2022 - Wiley Online Library
Background Sarcopenia is an important prognostic factor of lung cancer. The serum
creatinine/cystatin C ratio (CCR) and the sarcopenia index (SI, serum creatinine× cystatin C …
creatinine/cystatin C ratio (CCR) and the sarcopenia index (SI, serum creatinine× cystatin C …
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy
Y Suzuki, Y Aono, M Kono, H Hasegawa… - …, 2021 - Wiley Online Library
Background and objective Recent research has highlighted the fundamental role of
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach
P Faverio, A Fumagalli, S Conti, F Madotto, F Bini… - Respiratory …, 2022 - Springer
Background Sarcopenia gained importance in the evaluation of patients with chronic
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
The ratio serum creatinine/serum cystatin C (a surrogate marker of muscle mass) as a predictor of hospitalization in chronic obstructive pulmonary disease outpatients
CA Amado, MT García-Unzueta, BA Lavin, AR Guerra… - Respiration, 2019 - karger.com
Background: In chronic obstructive pulmonary disease (COPD), low muscle mass has been
associated with several clinical outcomes such as low exercise capacity, hospital admission …
associated with several clinical outcomes such as low exercise capacity, hospital admission …
相关搜索
- surrogate marker sarcopenia in patients
- surrogate marker muscle mass
- clinical outcomes sarcopenia in patients
- cause of mortality sarcopenia in patients
- frequency and impact sarcopenia in patients
- antifibrotic therapy sarcopenia in patients
- diagnostic indices serum creatinine
- surrogate marker predictor of hospitalization
- muscle quantification fibrosis patients
- surrogate marker older adults
- muscle mass fibrosis patients